文献速递毛发、甲与色素性疾病

白癜风患者抑郁症的患病率与比值比:一项荟萃分析

The prevalence and odds of depression in patients with vitiligo: a meta-analysis.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2018-01-23

白癜风患者出现抑郁的可能性是对照的4.96倍,亚组分析显示亚洲和女性患者抑郁患病率显著高于白种人和男性患者。

要点

  • 白癜风患者抑郁症合并患病率为29%(95%CI 20-39)。
  • 临床抑郁症患病率为8%(95%CI 2%-14%),抑郁症状患病率为33%(95%CI 23%-44%)。
  • 白癜风患者出现抑郁的可能性是对照的4.96倍。

核心结论

  • 本荟萃分析表明白癜风患者中抑郁症的患病率较高。
  • HDRS问卷可能是检测白癜风患者抑郁症状最敏感的工具。

研究设计与样本

  • 系统检索Medline、Embase和Cochrane图书馆数据库。

主要发现

  • 17个独立人群(n=1711)的抑郁症合并患病率为29%(95%CI 20-39)。
  • 使用DSM-IV或ICD-10编码的临床抑郁症患病率为8%(95%CI 2%-14%)。
  • 使用经验证的筛查量表和评定量表的抑郁症状患病率为33%(95%CI 23%-44%)。
  • 白癜风患者出现抑郁的可能性是对照的4.96倍。
  • 亚组分析显示亚洲和女性白癜风患者抑郁患病率显著高于白种人和男性患者。

关键数值与推荐

  • 使用HDRS问卷时抑郁症状合并患病率更高(56%,95%CI 0.5-0.62),且异质性较其他问卷降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to provide a pooled estimate of the prevalence and odds of depression in patients with vitiligo. METHODS: A systematic literature search of Medline, Embase and Cochrane library databases was conducted. The proportions and mean questionnaire values for depression were pooled according to different evaluation methods. In controlled studies, odds ratio and standardized mean differences compared depression in vitiligo patients with healthy controls. RESULTS: One thousand nine hundred and sixty-five patients were identified from 20 eligible cohorts to be included in the present meta-analysis review. Sample sizes ranged from 30 to 308 for each analysis. The pooled prevalence of depression across 17 unique populations (n = 1711) was 29% (95% CI 20-39). The prevalence of clinical depression was 8% (95% CI 2%-14%) using Diagnostic and Statistical Manual of Mental Disorders IV or International Classification of Diseases codes-10, and the prevalence of depressive symptoms was 33% (95% CI 23%-44%) using validated screening inventory and rating scales. Patient with vitiligo was 4.96 times more likely to display depression compared with controls. Subgroup analysis showed that the prevalence of depression in Asian and female patients with vitiligo was significantly higher than that in Caucasian and male ones. The pooled prevalence of depressive symptoms was higher (56%, 95% CI 0.5-0.62), and the heterogeneity was lowering cases with Hamilton Depression Rating Scale (HDRS) questionnaire when compared with other questionnaires. CONCLUSIONS: This meta-analysis review indicates that the prevalence of depression is high in patients with vitiligo. The HDRS questionnaire may be the most sensitive tool for testing the depressive symptoms among patients with vitiligo.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Wang G, Qiu D, Yang H, et al. The prevalence and odds of depression in patients with vitiligo: a meta-analysis. J Eur Acad Dermatol Venereol. 2018. PMID: 29222958. doi:10.1111/jdv.14739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。